Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Chinese group synthesizes new SGLT2 inhibitors

Sep. 26, 2012

Benefits seen with rhLAMAN in patients with alpha-mannosidosis

Sep. 26, 2012

CHMP recommends expanded approval of Trajenta tablets

Sep. 25, 2012

VIVUS anticipates CHMP opinion on Qsiva MAA

Sep. 25, 2012

Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease

Sep. 25, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

Bayer submits European MAA for contraceptive patch

Sep. 21, 2012

Novel cannabinoid CB1 receptor allosteric modulators discovered at University of Aberdeen

Sep. 21, 2012

Health Canada approves Byetta added on to insulin glargine

Sep. 20, 2012

Merck & Co. patents novel dipeptidyl peptidase inhibitors

Sep. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...